Inovio Pharmaceuticals Inc. Stock Rallies 4.0%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. advanced 4.0% to $0.77 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.6% to 26,445.45 and Dow Jones Industrial Average falling 0.3% to 53,791.85.

This was the stock's second consecutive day of gains.

Inovio Pharmaceuticals Inc. closed 74.3% below its 52-week high of $2.98, which the company achieved on September 9th.

The stock outperformed some of its peers, as Johnson & Johnson fell 0.8% to $259.80, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. fell 1.59% to $26.62.

Trading volume totaled 4.3 million, compared to the 50-day average of 2.7 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 11, 2026 16:35 ET (20:35 GMT)